| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328975 | Critical Reviews in Oncology/Hematology | 2012 | 4 Pages |
Abstract
Mediterranean area (MA) represents a zone of intermediate incidence (1–5/100,000) for NPC, the highest frequency being observed in North Africa (NA) where it is characterized by a bimodal age repartition due to a first adolescence peak. In MA and NA, NPC remain diagnosed at advanced stages which impact poorly on overall and disease-free survival. It's therapy in MA followed the progresses and standardisation of protocols, based on concomitant chemoradiotherapy (CCRT) alone or preceeded by induction chemotherapy (ICT) in advanced (N2–3, T3–4) stages, while localized cases are managed irradiation alone. NPC overall an disease-free survival improved, due to the use of combined chemo and radiotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Hamouda Boussen, Lilia Ghorbal, Lejri Naouel, Noureddine Bouaouina, Said Gritli, Farouk Benna, Jamel Daoud,